BPBT
FRTX

Boston Private Bank & Trust’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Boston Private Bank & Trust’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$24K Hold
8
– – ﹤0.01% 703
2014
Q4 		$26K Buy
+8
New +$28.3K ﹤0.01% 711

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Boston Private Bank & Trust's FRTX Position: Q1 2015 in Review

Boston Private Bank & Trust held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q1 2015 at 8 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #703.

Boston Private Bank & Trust first reported a position in FRTX in Q4 2014 and has held it in 2 quarters since. The position peaked at $26K in Q4 2014. 60 funds tracked by Wall St. Rank hold FRTX as of Q1 2015.

  • Boston Private Bank & Trust held 8 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $24K as of Q1 2015.
  • Boston Private Bank & Trust left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q1 2015.
  • Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #703 holding.
  • Boston Private Bank & Trust first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2014 and has held it in 2 quarters since.
  • Boston Private Bank & Trust's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $26K in Q4 2014.
  • 60 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.